Overview

Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned

Status:
Terminated
Trial end date:
2020-01-13
Target enrollment:
Participant gender:
Summary
To investigate the clinical effects of vilaprisan and ulipristal acetate at molecular and cellular level on uterine and fibroid tissue taken from patients (after surgery / biopsy)
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Ulipristal acetate